The FINANCIAL -- INDIANAPOLIS, June 25, 2018 /PRNewswire/ -- Eli Lilly and Company announced it will present Phase 3 data for galcanezumab and lasmiditan, two investigational, non-opioid treatments for migraine and cluster headache, at the American Headache Society annual meeting taking place June 28-July 1 in San ...

The FINANCIAL -- Tobacco use has declined markedly since 2000, according to a new WHO report, but the reduction is insufficient to meet globally agreed targets aimed at protecting people from death ...

The FINANCIAL -- The World Health Organization certified on June 12 that Paraguay as having eliminated malaria, the first country in the Americas to be granted this status since Cuba in ...

The FINANCIAL -- Hospitals are a central part of every healthcare system, and need to regularly evolve their infrastructure and facilities to keep up with new treatments and ...